Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-08
2005-03-08
McKenzie, Thomas C. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S210180, C514S318000, C514S326000, C514S330000, C546S193000, C546S208000, C546S209000, C546S210000, C546S211000, C546S212000, C546S213000, C546S226000, C548S953000
Reexamination Certificate
active
06864249
ABSTRACT:
The present invention relates to a compound having formula I:and pharmaceutically acceptable salts thereof. The compounds of formula I and pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants.
REFERENCES:
patent: 5914319 (1999-06-01), Schacht et al.
patent: 5932567 (1999-08-01), Seitz et al.
patent: WO 9937668 (1999-07-01), None
Jung Won Hyuk
Lee Koo
Lee Sang Koo
Lee Sun Hwa
Park Cheol Won
LG Life Sciences Ltd.
McKenzie Thomas C.
Reed Smith LLP
LandOfFree
Piperidine and azetidine thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine and azetidine thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine and azetidine thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3455143